Our findings indicated that they may be potential prognostic markers for ccRCC, in addition to suggesting that PI3K/AKT/mTOR pathway signaling abnormalities may be involved in ccRCC tumorigenesis and progression. The gene discussed is MTOR; the disease is nonpapillary renal cell carcinoma.